Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature-Reference-Cited by-同舟云学术

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature

Published:2017 Issue:4 Volume:9 Page:142
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:en
Short-container-title:WJGO

Author:

Galanopoulos Michail,Tsoukalas Nikolaos,Papanikolaou Ioannis S,Tolia Maria,Gazouli Maria,Mantzaris Gerassimos J

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference96 articles.

1. Cancer statistics, 2014

2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010; Available from: http://globocan.iarc.fr/.

3. Boyle P, Levin B. Cancer syte by syte-colorectal cancer. World cancer report 2008 Lyon: International Agency for Research on Cancer; 2008;374-379.

4. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma

5. Migliore L, Migheli F, Spisni R, Coppedè F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011;2011:792362.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics;Biosensors;2023-10-13

2. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas;Clinical Epigenetics;2023-10-04

3. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives;Cancers;2022-11-11

4. Epigenetics and its therapeutic potential in colorectal cancer;Epigenomics;2022-06

5. Omics-based biomarkers for CRC;Foundations of Colorectal Cancer;2022